Evaluates central hypothyroidism (CH) patients for adrenal insufficiency (AI) prior to initiating levothyroxine (L‑T4) replacement. Triggers include consideration of L‑T4 start in central hypothyroidism needing thyroid replacement.
Scanned 9/9/2026
Install to Claude Code
npx -y skills add dromlakhani/MD2SKILL --skill ata-ch-ai-screening-lt4 --agent claude-codeInstalls into .claude/skills of the current project.
Are you the author of Ata Ch Ai Screening Lt4?
Add the live security badge to your README — it updates automatically with every re-scan.
[](https://www.skillsdirectory.com/skills/dromlakhani-ata-ch-ai-screening-lt4)More formats (shields.io, HTML) on the badges page.
---
name: ata-ch-ai-screening-lt4
description: Evaluates central hypothyroidism (CH) patients for adrenal insufficiency (AI) prior to initiating levothyroxine (L‑T4) replacement. Triggers include consideration of L‑T4 start in central hypothyroidism needing thyroid replacement.
---
# Screen central hypothyroidism patients for adrenal insufficiency before levothyroxine
## STEP 1 — Gather Information
Confirm CH diagnosis: low or low‑normal free T4 (fT4) with non‑elevated TSH in the setting of pituitary disease; assess hypothyroid symptoms; obtain baseline morning serum cortisol (8‑9 AM) if feasible.
## STEP 2 — Rule In / Rule Out
Determine if AI testing is feasible (morning cortisol or ACTH stimulation test can be performed). If not feasible, proceed to empiric glucocorticoid therapy; if feasible, move to biochemical evaluation.
## STEP 3 — Classify or Stratify
Interpret morning cortisol: <3 µg/dL suggests AI; >15 µg/dL makes AI unlikely; values 3‑15 µg/dL require low‑dose (1 µg) or standard‑dose (250 µg) ACTH stimulation test, with peak cortisol <18.1 µg/dL indicating AI.
## STEP 4 — Decide
If AI is confirmed, initiate glucocorticoid replacement (e.g., hydrocortisone 15‑20 mg daily in divided doses) before starting L‑T4; if AI is ruled out, begin L‑T4 therapy targeting mid‑to‑upper reference range fT4; if testing was not feasible, prescribe empiric glucocorticoid therapy (same dosing) while arranging definitive AI evaluation.
## Clinical Guardrails / Mimics / Pitfalls
Do not start L‑T4 without assessing AI due to risk of precipitating adrenal crisis; avoid random cortisol for diagnosis; do not use fludrocortisone in secondary AI; ensure patients receive stress‑dose education and emergency glucocorticoid kit; remember that estrogen can raise total cortisol via CBG, potentially masking AI.
## Concrete Clinical Example
A 50‑year‑old man with non‑functioning pituitary adenoma post‑resection presents with low fT4 and normal TSH; morning cortisol is 2.5 µg/dL (<3 µg/dL), confirming AI; he receives hydrocortisone 10 mg on waking and 5 mg in the afternoon before L‑T4 is started.
**Source:** Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, DOI:10.1210/jc.2016-2118
Is this your skill, or is something wrong with this listing? Request removal or report an issue. Author removals are honored within 72 hours.
No comments yet. Be the first to comment!